Published in Br J Dermatol on January 22, 2010
The porphyrias: advances in diagnosis and treatment. Blood (2012) 1.34
The incidence of inherited porphyrias in Europe. J Inherit Metab Dis (2012) 1.10
Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria. Am J Hum Genet (2014) 0.77
Advances in the management of erythropoietic protoporphyria - role of afamelanotide. Appl Clin Genet (2016) 0.75
Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias. Curr Protoc Hum Genet (2015) 0.75
Modelling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice. Dis Model Mech (2017) 0.75
Valuable insights from molecular genetic studies in the porphyrias. Br J Dermatol (2010) 0.75
Clinical implications of advances in understanding the inheritance of erythropoietic protoporphyria. Br J Dermatol (2010) 0.75
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias. Clin Chem (2015) 0.75
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. J Inherit Metab Dis (2017) 0.75
Economic stress, coercive family process, and developmental problems of adolescents. Child Dev (1994) 5.45
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
A family process model of economic hardship and adjustment of early adolescent boys. Child Dev (1992) 4.32
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol (2009) 4.12
Pubertal transition, stressful life events, and the emergence of gender differences in adolescent depressive symptoms. Dev Psychol (2001) 3.79
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol (2005) 3.10
Competence in early adult romantic relationships: a developmental perspective on family influences. J Pers Soc Psychol (2000) 2.87
Macrocyclic intermediates in the biosynthesis of porphyrins. Philos Trans R Soc Lond B Biol Sci (1976) 2.73
Are religious grandparents more involved grandparents? J Gerontol B Psychol Sci Soc Sci (1999) 2.36
Couple resilience to economic pressure. J Pers Soc Psychol (1999) 2.09
Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev (1996) 2.08
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol (2006) 1.77
Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet (1997) 1.69
Pathways of economic influence on adolescent adjustment. Am J Community Psychol (1999) 1.69
A radiochemical method for the measurement of coproporphyrinogen oxidase and the utilization of substrates other than coproporphyrinogen III by the enzyme from rat liver. Biochem J (1978) 1.58
Continuities and consequences of interactional styles across the life course. J Pers (1989) 1.52
Linking family hardship to children's lives. Child Dev (1985) 1.52
ACP Best Practice No 165: front line tests for the investigation of suspected porphyria. J Clin Pathol (2001) 1.50
Cercarial dermatitis in the UK. Clin Exp Dermatol (2008) 1.49
Parent-adolescent reciprocity in negative affect and its relation to early adult social development. Dev Psychol (2001) 1.49
The efficacy of a serum screening service for neural-tube defects: the South Wales experience. Lancet (1983) 1.49
Aquagenic pruritus responding to intermittent photochemotherapy. Clin Exp Dermatol (2001) 1.41
Hydroxychloroquine-induced pruritus. Acta Derm Venereol (1999) 1.40
Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med (1978) 1.39
A MspI polymorphism for the human porphobilinogen deaminase gene. Nucleic Acids Res (1987) 1.37
Guideline for the diagnosis and management of vitiligo. Br J Dermatol (2008) 1.35
Porphyrin metabolism in porphyria cutanea tarda. Semin Hematol (1977) 1.35
Can we afford screening for neural tube defects? The South Wales experience. Br Med J (Clin Res Ed) (1985) 1.34
A 50-year prospective study of the psychological sequelae of World War II combat. Am J Psychiatry (1995) 1.29
The porphyrias: a review. J Clin Pathol (1972) 1.28
Evidence that the coproporphyrinogen oxidase activity of rat liver is situated in the intermembrane space of mitochondria. Biochem J (1978) 1.26
A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. Br J Dermatol (2012) 1.25
Husband and wife differences in response to undesirable life events. J Health Soc Behav (1993) 1.24
Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces. J Clin Pathol (1975) 1.24
The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat. Clin Sci Mol Med (1976) 1.24
Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway. J Immunol (2001) 1.23
The intergenerational transmission of health-risk behaviors: adolescent lifestyles and gender moderating effects. J Health Soc Behav (1999) 1.23
British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Br J Dermatol (2011) 1.23
Investigation of the subcellular location of the tetrapyrrole-biosynthesis enzyme coproporphyrinogen oxidase in higher plants. Biochem J (1993) 1.18
DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria. Lancet (1987) 1.17
Appearance and education in marriage mobility. Am Sociol Rev (1969) 1.16
Changes in free calcium in the endoplasmic reticulum of living cells detected using targeted aequorin. Anal Biochem (1994) 1.15
Family history and the life course. J Fam Hist (1977) 1.15
Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases. Br J Dermatol (2012) 1.13
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? Lancet (1981) 1.12
Variations in registration of skin cancer in the United Kingdom. Clin Exp Dermatol (2004) 1.12
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet (1985) 1.11
Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver. Biochem J (1983) 1.11
Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol (2007) 1.10
Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase. Clin Sci (Lond) (1980) 1.09
Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. QJM (2002) 1.09
Worklives and longevity: insights from a life course perspective. J Health Soc Behav (1993) 1.09
The primary enzyme defect in hereditary coproporphyria. Lancet (1976) 1.08
Isocoproporphyrin: nuclear-magnetic-resonance-and mass-spectral methods for the determination of porphyrin structure. Biochem J (1973) 1.04
Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology (1998) 1.04
Aequorea victoria bioluminescence moves into an exciting new era. Trends Biotechnol (1998) 1.01
Adult primary cutaneous Langerhans' cell histiocytosis mimicking nodular prurigo. Clin Exp Dermatol (2002) 1.01
Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene. Biochem Biophys Res Commun (1982) 1.00
A comparison of the response of unstimulated and stimulated T-lymphocytes and fibroblasts from normal, xeroderma pigmentosum and trichothiodystrophy donors to the lethal action of UV-C. Mutat Res (1992) 0.99
Intergenerational continuity of parental rejection and depressed affect. J Pers Soc Psychol (1992) 0.99
Factors determining the sequence of oxidative decarboxylation of the 2- and 4-propionate substituents of coproporphyrinogen III by coproporphyrinogen oxidase in rat liver. Biochem J (1978) 0.99
Decreased activity of uroporphyrinogen decarboxylase caused by 2,4,5,3',4'-pentabromobiphenyl in chick embryo hepatocyte cultures. Difference in activity in intact or homogenized cells. FEBS Lett (1983) 0.98
The metabolism of porphyrins of the isocoproporphyrin series. Enzyme (1974) 0.98
Acute intermittent porphyria caused by a C----T mutation that produces a stop codon in the porphobilinogen deaminase gene. Hum Genet (1990) 0.97
Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda. Lancet (1983) 0.96
Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction. Enzyme (1982) 0.96
Economic hardship and marital relations in the 1930s. Am Sociol Rev (1983) 0.95
The porphyrias: clinical chemistry, diagnosis and methodology. Clin Haematol (1980) 0.94
Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol (2001) 0.94
Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet (1999) 0.93
Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members. Br J Dermatol (2007) 0.93
Management of acute and cutaneous porphyrias. Int J Clin Pract (2002) 0.92
Enzymatic defects in porphyria: an overview. Semin Liver Dis (1982) 0.92
Matrilineal advantage in grandchild-grandparent relations. Gerontologist (2000) 0.92
Life satisfaction in old age: linking social psychology and history. Psychol Aging (1986) 0.92
Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet (2004) 0.91
Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop. Br J Dermatol (2002) 0.91
Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene. Hum Genet (1992) 0.90
UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and xeroderma pigmentosum donors in the comet assay: a potential diagnostic technique. Mutat Res (1992) 0.89
Molecular characterization of homozygous variegate porphyria. Hum Mol Genet (1998) 0.89
Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid. Biochem J (1988) 0.89
Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase. Hum Mol Genet (1993) 0.88
Recombinant apoaequorin acting as a pseudo-luciferase reports micromolar changes in the endoplasmic reticulum free Ca2+ of intact cells. Biochem J (1996) 0.88
Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol (1993) 0.88
Late-onset erythropoietic protoporphyria in association with haematological malignancy. Clin Exp Dermatol (2006) 0.88
Isolation of an hydroxylated porphyrin from urine and faeces of patients with cutaneous hepatic porphyria. Biochim Biophys Acta (1970) 0.88
Homozygous variegate porphyria: a case report. Br J Dermatol (1990) 0.88
Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria. Am J Hum Genet (2001) 0.88
Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy. Br J Dermatol (2006) 0.87
Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutations. Hum Genet (1999) 0.87
Urinary catecholamines and metabolites in the immediate postoperative period following major surgery. J Clin Pathol (2004) 0.87